FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $2.04, $0.06 better than the analyst estimate of $1.98. Revenue for the quarter came in at $2.33 billion versus the consensus estimate of $2.2 billion.
GUIDANCE:
Quest Diagnostics sees Q2 2023 EPS of $8.45-$8.95, versus the consensus of $8.71.... More

